Tartaric Acid

• . Uses: Uses: For temporary relief of minor: indigestion* bloating* fatigue* difficult bowel movements* flatulence* diarrhea* *Claims based on traditional homeopathic practice, not accepted medical evidence.

Directions: Adults & children ages 12 years and over: Take 12 drops under the tongue 3 times a day, or as directed by your healthcare professional. Consult a physician for use in children under 12 years of age.

If pregnant or breastfeeding , ask a health professional before use. Do not use if clear seal over the cap is broken or missing. Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away. Stop use and ask a doctor if indigestion, bloating, fatigue, difficult bowel movements, flatulence, diarrhea, or other symptoms do not improve within 7 days or are accompanied by fever.

1. 1Fatigue1389.1%
2. 2Nausea1228.1%
3. 3Dizziness1067.0%
4. 4Pain996.5%
5. 5Diarrhoea976.4%
6. 6Headache976.4%
7. 7Arthralgia865.7%
8. 8Drug Ineffective845.5%
9. 9Dyspnoea785.2%
10. 10Pain In Extremity734.8%
11. 11Pruritus684.5%
12. 12Asthenia664.4%
13. 13Vomiting634.2%
14. 14Insomnia604.0%
15. 15Rash563.7%

Recent PubMed references pinned to Tartaric Acid as a MeSH major topic. Citations link to pubmed.ncbi.nlm.nih.gov.

• Qualitative and Quantitative Characteristics of Organic Acids in Monofloral and Honeydew Honeys from Poland: Is There a Varietal Pattern in Their Composition?
  Molecules (Basel, Switzerland) · 2025 · Szczęsna T, Jaśkiewicz K, Jachuła J, et al.
  PMID 41226221DOI 10.3390/molecules30214261
• Virucidal Efficacy of Organic Acids and Plant Essential Oils.
  Food and environmental virology · 2025 · Silva-Beltran NP, Boone SA, Lehman JQ, et al.
  PMID 40883554DOI 10.1007/s12560-025-09660-4
• A Laboratory Investigation of the Effectiveness of Different Acids in Removing Mineral Trioxide Aggregate From Simulated Root Canals.
  Australian endodontic journal : the journal of the Australian Society of Endodontology Inc · 2025 · Chan S, Abbott PV
  PMID 40125883DOI 10.1111/aej.12937
• A sustainable one-step approach for the functionalized cellulose nanocrystal production using recyclable organic acids: Exploring structure-property dynamics.
  International journal of biological macromolecules · 2025 · Cherian RM, Antony T, Varghese RT, et al.
  PMID 39978495DOI 10.1016/j.ijbiomac.2025.141192
• Tartaric acid, an effective additive to improve the surface properties and bio-corrosion resistance of HA-coated magnesium-based implants.
  International journal of biological macromolecules · 2025 · Mardani Korrani A, Zargarian S, Eivaz Mohammadloo H, et al.
  PMID 39805441DOI 10.1016/j.ijbiomac.2025.139792
• Adaptive responses of Alicyclobacillus acidoterrestris in acidic broth and fruit juices: Focus on the influences of organic acids and temperature conditions.
  International journal of food microbiology · 2025 · Zhao N, Zhang Y, Li J, et al.
  PMID 39799880DOI 10.1016/j.ijfoodmicro.2025.111058
• Synthesis of terpinyl acetate from α-pinene catalyzed by α-hydroxycarboxylic acid-boric acid composite catalyst.
  PloS one · 2024 · Meng Z, Qin R, Wen R, et al.
  PMID 38662654DOI 10.1371/journal.pone.0299218
• Study on the accumulation pattern of anthocyanins, sugars and organic acids in medicinal Vitis vinifera 'SuoSuo' during ripening.
  Food chemistry · 2024 · Wang L, Zhou W, Liu C, et al.
  PMID 37659294DOI 10.1016/j.foodchem.2023.137294

The 10 most recently updated of 27 ClinicalTrials.gov registrations naming Tartaric Acid as an intervention. Registration is not evidence of efficacy or safety — reference crosswalk only.

• A Study in Healthy Men to Test How Well Different Doses of BI 1569912 Are Tolerated and How Food Influences the Amount of BI 1569912 in the Blood
  Terminated · Phase 1 · Interventional · 68 enrolled · Boehringer Ingelheim
  NCT04445090updated 2026-05-22
• Pharmacokinetic Characterization of Tartaric Acid in Humans
  Not yet recruiting · Interventional · 30 enrolled · Fundacion Clinic per a la Recerca Biomédica
  NCT07394101updated 2026-02-06
• This Study Tests How Different Doses of BI 1291583 Are Taken up in the Body and How Well They Are Tolerated
  Terminated · Phase 1 · Interventional · 54 enrolled · Boehringer Ingelheim
  NCT03414008updated 2025-08-13
• Safe and Effective Delivery of Supplemental Iron to Healthy Volunteers
  Completed · Interventional · 226 enrolled · Tufts University
  NCT03212677updated 2025-04-25
• Influence of Fluvoxamine on the Pharmacokinetics of BI 409306
  Completed · Phase 1 · Interventional · 18 enrolled · Boehringer Ingelheim
  NCT02853136updated 2024-08-21
• Nutritional Stimulation of Growth in Children With Short Stature
  Completed · Interventional · 24 enrolled · Arkansas Children's Hospital Research Institute
  NCT04226586updated 2024-07-31
• Study on Gynecological Laparoscopy Under Total Intravenous Anesthesia
  Completed · Interventional · 59 enrolled · Wuhan Children's Hospital
  NCT06524596updated 2024-07-29
• Safety Tolerability and Pharmacokinetic of BI 409306
  Completed · Phase 1 · Interventional · 80 enrolled · Boehringer Ingelheim
  NCT01343706updated 2024-04-25
• Envarsus in Delayed Graft Function (E-DGF)
  Completed · Phase 4 · Interventional · 100 enrolled · University of Wisconsin, Madison
  NCT03864926updated 2023-07-20
• Studies on the Impact of Taste-aware Intelligent Analysis of Oral Nutritional Supplements
  Unknown · Observational · 108 enrolled · Peking Union Medical College Hospital
  NCT05651321updated 2023-04-12

Frequently asked questions

What is Tartaric Acid used for?

According to FDA labeling, Tartaric Acid carries indications including: . Uses: Uses: For temporary relief of minor: indigestion* bloating* fatigue* difficult bowel movements* flatulence* diarrhea* *Claims based on traditional homeopathic practice, not accepted medical evidence.. This is a reference summary of labeled uses, not medical advice or a treatment recommendation.